Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eltrombopag in CMML with Thrombocytopenia
NCT02323178Phase 2Completed
- Sponsor
- Groupe Français des Myélodysplasies
- Start
- Aug 2014
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of eltrombopag in Thrombocytopenia, sponsored by Groupe Français des Myélodysplasies. Started Aug 2014; status: completed.
02
Drugs
eltrombopag
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on NCT02323178.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02323178.